First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors-Reference-Cited by-同舟云学术

First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors

Published:2019-02-23 Issue:7 Volume:145 Page:1798-1808
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Garrido-Laguna Ignacio¹,Krop Ian²,Burris Howard A.³,Hamilton Erika³,Braiteh Fadi⁴,Weise Amy M.⁵,Abu-Khalaf Maysa⁶,Werner Theresa L.¹,Pirie-Shepherd Steven⁷,Zopf Christopher J.⁷,Lakshminarayanan Mani⁷,Holland Jaymes S.⁷,Baffa Raffaele⁷,Hong David S.⁸^ORCID

Affiliation:

1. Department of Medicine, Huntsman Cancer Institute, University of Utah; Salt Lake City UT

2. Department of Medical Oncology, Dana-Farber Cancer Center/Brigham and Women's Hospital; Boston MA

3. Department of Medical Oncology, Sarah Cannon Research Institute/Tennessee Oncology; Nashville TN

4. Department of Medical Oncology, Comprehensive Cancer Centers of Nevada and University of Nevada Las Vegas School of Medicine; Las Vegas NV

5. Department of Oncology, Barbara Ann Karmanos Cancer Institute; Detroit MI

6. Department of Breast Medical Oncology, Thomas Jefferson University; Philadelphia PA

7. Pfizer Inc., Oncology; San Diego CA

8. Department of Investigational Cancer Therapeutics, University of Texas M. D. Anderson Cancer Center; Houston TX

Funder

Pfizer

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.32154/fullpdf

Reference31 articles.

1. Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers;Hafner;Clin Chem,2004

2. Eph receptor and ephrin function in breast, gut, and skin epithelia;Perez White;Cell Adh Migr,2014

3. The role of ephrins and Eph receptors in cancer;Surawska;Cytokine Growth Factor Rev,2004

4. Eph receptors and ephrins in cancer: bidirectional signaling and beyond;Pasquale;Nat Rev Cancer,2010

5. Expression of Ephb2 and Ephb4 in breast carcinoma;Wu;Pathol Oncol Res,2004

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress of antibody–drug conjugates in gynecologic cancer;Holistic Integrative Oncology;2024-08-29

2. Clinical translation of antibody drug conjugate dosing in solid tumors from preclinical mouse data;Science Advances;2024-05-31

3. EFNA4 as a potential prognostic biomarker and therapeutic target for GBMLGG;2024-01-30

4. Preclinical Characterization of Catabolic Pathways and Metabolism of ABBV-011, a Novel Calicheamicin-Based SEZ6-Targeting Antibody-Drug Conjugate;Drug Metabolism and Disposition;2023-12-01

5. Antibody-drug conjugates in HER-2 negative breast cancers with poor prognosis;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11